新型冠状病毒肺炎疫情防控的捐赠药品管理策略

徐晓涵, 杨丽, 陈晨, 翟所迪, 赵荣生

中国药学杂志 ›› 2020, Vol. 55 ›› Issue (9) : 700-703.

PDF(3236 KB)
PDF(3236 KB)
中国药学杂志 ›› 2020, Vol. 55 ›› Issue (9) : 700-703. DOI: 10.11669/cpj.2020.09.006
新冠疫情防控专栏

新型冠状病毒肺炎疫情防控的捐赠药品管理策略

  • 徐晓涵, 杨丽, 陈晨, 翟所迪, 赵荣生*
作者信息 +

Management Strategy on Donated Medicines for COVID-19 Prevention and Control

  • XU Xiao-han, YANG Li, CHEN Chen, ZHAI Suo-di, ZHAO Rong-sheng*
Author information +
文章历史 +

摘要

目的 为药学部门应对突发公共卫生事件做好捐赠药品管理工作提供参考,以确保捐赠药品质量安全及合理使用。方法 结合捐赠药品相关法律规制要求和常见问题,探讨科学合理的捐赠药品管理原则、建立捐赠药品管理制度和流程。结果 既往医疗机构在应对重大突发事件期间,对捐赠药品的需求、资质与质量、有效期、使用、价格和剩余药品等管理方面存在一些问题。根据相关法律、法规和指导文件对于捐赠药品特性、管理、使用和供受双方沟通等方面的要求,建立科学、合理、有序的捐赠药品管理模式,明确管理制度、方法和综合管理流程。结论 本文对于捐赠药品的管理问题、管理原则和管理模式进行了全面梳理,有助于防控新型冠状病毒肺炎疫情期间医疗机构药学部门提高捐赠药品管理水平。

Abstract

OBJECTIVE To provide reference of donated drugs management for pharmaceutical departments during public health emergencies, so as to ensure the quality, safety and reasonable use of donated drugs. METHODS Combined with the legal requirements and common problems of donated drugs, explore scientific and reasonable donated drug management principles, and establish donated drug management systems and processes. RESULTS In the past, when medical institutions responded to major public health emergencies, there were some problems in the management of the demand, qualification and quality, validity, use, price, and surplus drugs of donated drugs. According to the requirements of the relevant laws, regulations and guidance on the characteristics, management, use and communication between donors and recipients of donated drugs, we established a scientific, reasonable and orderly management model, and clarified the management system, method and comprehensive management process. CONCLUSION The problems, principles and models of donated drugs management were sorted out comprehensively, which is helpful to prevent and control of coronavirus disease 2019 (COVID-19).

关键词

捐赠药品 / 新型冠状病毒肺炎 / 药品管理

Key words

donated medicines / COVID-19 / pharmaceutical administration

引用本文

导出引用
徐晓涵, 杨丽, 陈晨, 翟所迪, 赵荣生. 新型冠状病毒肺炎疫情防控的捐赠药品管理策略[J]. 中国药学杂志, 2020, 55(9): 700-703 https://doi.org/10.11669/cpj.2020.09.006
XU Xiao-han, YANG Li, CHEN Chen, ZHAI Suo-di, ZHAO Rong-sheng. Management Strategy on Donated Medicines for COVID-19 Prevention and Control[J]. Chinese Pharmaceutical Journal, 2020, 55(9): 700-703 https://doi.org/10.11669/cpj.2020.09.006
中图分类号: R969   

参考文献

[1] ZHAO R S, YANG Y H, YANG L, et al. CORONAVIRUS SARS-CoV-2 INFECTION: expert consensus on guidance and prevention strategies for hospital pharmacists and the pharmacy workforce (2nd edition) [J]. Chin Pharm J(中国药学杂志), 2020, 55(4):268-277.
[2] World Health Organization. Guidelines for medicine donations revised 2010. [EB/OL]. Global Website of World Health Organization, 2011 [2020-03-10]. https://www.who.int/medicines/publications/med_donationsguide2011/en/.
[3] SUN P D, LI D K. New issues brought by SARS——how to manage donated medicines [J]. Clin Med J(临床药物治疗杂志), 2003(2):7.
[4] CHEN M, TONG R S. Consideration on management and use of donated drugs for earthquake resistance and disaster relief[J]. J China Pharm(中国药房), 2009, 20(22):1695-1696.
[5] SHI J, JING H. Analysis of donated medicines management of emergencies[J]. China Market(中国市场), 2016(4):65-66.
[6] XIAO H T, CHEN Q H, CHEN L, et al. Principles and suggestions for improvement for accepting (receiving) donated medicines[J]. Chin Pharm J(中国药学杂志), 2010, 45(12):959-960.
[7] The National People's Congress of the People's Republic of China. Law of the People's Republic of China on public welfare donations (Presidential Order of the People's Republic of China No. 19) [EB/OL]. The official website of the National People's Congress, 1999 [2020-03-11]. http://www.npc.gov.cn/wxzl/wxzl/2008-12/15/content_1462090.htm.
[8] The National People's Congress of the People's Republic of China. Charity law of the People's Republic of China (Presidential Order of the People's Republic of China No. 43)[EB/OL]. The official website of the National People's Congress, 2016 [2020-03-11].http://www.npc.gov.cn/npc/c10134/201603/6c423747f9df4c27adb1b7e45815f025.shtml.
[9] Ministry of Civil Affairs of the People's Republic of China. Interim measures for the administration of disaster relief donations (Decree of the Ministry of Civil Affairs of the People's Republic of China No. 35) [EB/OL]. The Chinese Government Website, 2008 [2020-03-11]. http://www.gov.cn/flfg/2008-05/09/content_965425.htm.
[10] Chinese Food and Drug Administration. Notice on the interim provisions on donations of SARS medicines and medical devices (Chinese Food and Drug Administration [2003] No. 35)[EB/OL]. PHARMNET, 2003 [2020-03-11]. http://www.gxfda.gov.cn/gxfdanet/BMWJ00110/7315.jhtml.
[11] Ministry of Health, National Administration of Traditional Chinese Medicine. Notice on interim measures for the administration of acceptance of social donation funding in medical and health institutions ( [2007] No. 117) [EB/OL]. The official website of National Administration of Traditional Chinese Medicine, 2007 [2020-03-11]. http://www.satcm.gov.cn/fajiansi/gongzuodongtai/2018-03-24/2296.html.
[12] Chinese Food and Drug Administration. Notice on strengthening the supervision of donations of disaster relief drugs and medical devices (Chinese Food and Drug Administration [2008] No. 20) [EB/OL]. The official website of Chinese Food and Drug Administration, 2008[2020-03-11].http://samr.cfda.gov.cn/WS01/CL0852/29736.html.
[13] Chinese Food and Drug Administration. Notice on further supervising the donations of disaster relief drugs and medical devices (Chinese Food and Drug Administration [2008] No. 21)[EB/OL]. The official website of Chinese Food and Drug Administration, 2008 [2020-03-11]. http://samr.cfda.gov.cn/WS01/CL0845/29803.html.
[14] Chinese Food and Drug Administration, Ministry of Civil Affairs, National Health and Family Planning Commission, et al. Regulations on the administration of the import of donated medicines ( [2016] No.  66) [EB/OL]. The official website of Ministry of Commerce of The People's Republic of China, 2008[2020-03-11]. http://www.mofcom.gov.cn/article/b/g/201607/20160701365954.shtml.
[15] ZHANG J Y. Medicine-special commodities[J]. Chin Pharm Aff(中国药事),1987,1(1):33-35.
[16] MCPHERSON S, REESE C, WENDLER M C. Methodology update: delphi studies[J]. Nurs Res, 2018, 67(5):404-410.
[17] XU T, JIN Z H, MA Y, et al. Operation mode for the management of donated medicines[J]. J China Pharm(中国药房), 2008, 19(25):1956-1957.

PDF(3236 KB)

Accesses

Citation

Detail

段落导航
相关文章

/